Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.91 USD | +2.25% | -1.92% | -33.91% |
May. 07 | MoonLake Immunotherapeutics Q1 Net Loss Widens | MT |
May. 07 | MoonLake Immunotherapeutics Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.91% | 2.45B | |
+9.99% | 114B | |
+12.01% | 107B | |
-3.07% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-6.90% | 17.51B | |
-39.36% | 17.17B | |
+5.82% | 14.14B | |
+33.05% | 12.2B |
- Stock Market
- Equities
- MLTX Stock
- News MoonLake Immunotherapeutics
- Guggenheim Adjusts MoonLake Immunotherapeutics' Price Target to $77 From $70, Maintains Buy Rating